- FDA and Brigham and Women’s Hospital have expanded their previous RCT DUPLICATE demonstration project to predict the results of seven Phase IV trails that are currently ongoing
- Part of the project will estimate the results of randomised controlled trials before they are finished with the use of RWE
Click here to see the source article
Hale, C. (2019). Using real-world data, the FDA aims to predict randomized trial results before they’re done. [online] FierceBiotech. Available at: https://www.fiercebiotech.com/medtech/using-real-world-data-fda-aims-to-predict-randomized-trial-results-before-they-re-done [Accessed 21 May 2019].
SVMPharma is an innovative strategic consultancy, specialising in Real World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.